Albemarle Corporation (NYSE: ALB) is the world’s largest producer of converted lithium chemicals by volume, with FY2025 revenue of $5.1 billion — up from $4.4 billion in 2024 — as global Albemarle lithium output underpinned a recovery year marked by cost discipline and strategic asset rationalisation. The company controls three of the most strategically significant lithium assets on the planet, spanning the Atacama brine fields of Chile, the hard rock spodumene operations of Western Australia, and a development-stage domestic US deposit positioned to benefit from IRA incentives.
Company Overview
Albemarle is a Charlotte, North Carolina-based specialty chemicals company with two primary divisions: lithium and bromine. The lithium division generates the majority of revenue and is the primary growth engine; bromine — largely a duopoly with ICL Group — provides a stable earnings floor. The company has built its lithium business around battery-grade chemicals: lithium carbonate and lithium hydroxide, the latter increasingly preferred for high-nickel cathode chemistries used in long-range EV applications.
Full-year 2025 adjusted EBITDA reached $1.1 billion. The company entered 2026 with approximately $3.2 billion in liquidity, including $1.6 billion in cash, and a net debt to adjusted EBITDA ratio of around 2.0x — a position that reflects deliberate capital management through the 2023–2024 lithium price trough. Q4 2025 net sales of $1.4 billion came in 16% above the prior year period.
Cost reduction has been a central focus. Albemarle achieved approximately $450 million in annualised cost and productivity improvements in 2025 and is targeting a further $100–150 million in 2026. The company’s ability to weather the lithium downturn without cutting primary production is a structural differentiator. For more on North American critical minerals supply chains, see critical minerals North America.
Albemarle Lithium — Key Assets and Operations
Salar de Atacama, Chile — Albemarle’s brine lithium operations in Chile’s Atacama Desert sit on the world’s highest-grade lithium deposit. The Atacama produces lithium concentrate (brine) processed at the La Negra conversion facility into battery-grade lithium carbonate and hydroxide. The resource remains the company’s lowest-cost production base.
Greenbush, Western Australia — Albemarle holds a minority stake in the Greenbush spodumene mine through a joint venture with Tianqi Lithium and IGO Limited. Greenbush is the world’s largest hard rock lithium mine by output. Spodumene concentrate from Greenbush feeds downstream conversion plants, including the now-idling Kemerton hydroxide facility.
Kings Mountain, North Carolina — A hard rock lithium deposit in development on Albemarle’s historic Kings Mountain mining district. The company is testing direct lithium extraction (DLE) and novel processing techniques at the site. Kings Mountain’s location in the US Southeast positions it as an IRA-compliant domestic lithium source for American battery and EV manufacturers. Full-scale production remains several years out.
Kemerton, Western Australia — Albemarle’s lithium hydroxide conversion plant at Kemerton is being idled in 2026. The decision reflects the structural cost gap between Western processing operations and Chinese conversion capacity — a gap that has widened as Chinese lithium chemical producers benefit from lower energy costs and integrated supply chains. Albemarle does not expect Kemerton’s idling to affect sales volumes; the company is redirecting production through other conversion assets.
Lithium Market Position and Pricing
Albemarle’s primary products — battery-grade lithium carbonate and lithium hydroxide — serve global cell manufacturers and OEMs directly. The company has disclosed customer relationships with Ford and Tesla, among others. Lithium hydroxide commands a premium for use in NMC (nickel manganese cobalt) cathodes at high nickel loadings, where energy density demands exceed what lithium iron phosphate (LFP) chemistry can deliver.
Lithium prices fell approximately 80% from their 2021–22 peak to a 2024 trough, compressing margins across the industry. A partial recovery is underway in 2026. Analysts have cited potential for prices to recover above $20,000 per tonne if the current supply glut clears — a scenario contingent on Chinese production discipline and continued EV and battery energy storage demand growth. Albemarle raised its 2030 global lithium demand forecast by 10% in late 2025 to a range of 2.8–3.6 million metric tonnes of lithium carbonate equivalent (LCE). Global demand reached 1.6 million metric tonnes LCE in 2025, up more than 30% year-on-year, with battery energy storage systems (BESS) emerging as a significant second demand driver alongside EVs.
Wall Street sentiment on Albemarle shifted cautiously bullish in early 2026, with upgrades from Goldman Sachs and J.P. Morgan. The stock remains highly leveraged to lithium spot prices — a characteristic that amplifies both upside and downside versus peers with more diversified commodity exposure. See the full top 10 lithium mining companies for a broader view of the competitive landscape.
Strategic Direction and Recent Developments
Albemarle’s 2025–2026 strategy centres on three themes: cost reduction, asset rationalisation, and positioning for the next lithium price cycle. The Kemerton idling is the most visible operational move — a recognition that Western conversion economics are not currently competitive with Chinese peers on a standalone basis. Rather than absorb ongoing losses, Albemarle has chosen to consolidate conversion around its lowest-cost assets.
On the divestiture side, Albemarle sold its majority stake in the Ketjen refining catalyst division — a transaction completed or in late stages as of Q1 2026 — and completed the sale of its stake in the Eurocat joint venture in January 2026. Both moves sharpen the company’s focus on lithium as the primary growth business and reduce balance sheet complexity ahead of the anticipated price recovery cycle.
At Kings Mountain, Albemarle’s DLE and processing technology work represents a longer-term bet on US domestic production. If successful at commercial scale, Kings Mountain could supply IRA-qualifying lithium to US cell manufacturers — a strategic position that no other large-cap lithium producer currently holds on American soil.
Risks and Competitive Landscape
Albemarle’s revenue is materially sensitive to lithium spot prices. The company’s cost reduction programme has improved its resilience at the trough, but a sustained period of low prices — driven by Chinese oversupply or slower-than-expected EV adoption — would compress EBITDA significantly. Total debt stands at $3.2 billion; the 2.0x net debt ratio is manageable but leaves limited headroom for further downturn without either equity issuance or asset sales.
The competitive landscape has intensified. Rio Tinto’s $6.7 billion acquisition of Arcadium Lithium, completed in March 2025, brought a major diversified miner with a large balance sheet directly into the converted lithium chemicals market. SQM of Chile remains a primary rival in brine production. Tianqi Lithium — simultaneously a JV partner at Greenbush and a competitor in the Chinese market — adds a layer of strategic complexity to Albemarle’s supply chain relationships.
Kemerton’s idling highlights a broader structural challenge: Western lithium processing capacity cannot currently match Chinese conversion costs. Until Western governments either subsidise conversion or Chinese capacity is constrained by policy, this gap will persist. Albemarle’s response — consolidation rather than continued investment in uncompetitive capacity — is rational but underscores the limits of reshoring ambitions in battery materials without direct state support.
Bromine markets face separate headwinds. Demand from automotive and building and construction end-markets has been weak, partially offsetting the bromine division’s role as an earnings stabiliser. This is not a critical minerals story in itself, but it reduces the earnings floor that bromine has historically provided.
Company Snapshot
| Detail | Data |
|---|---|
| Founded | 1994 (spun off from Ethyl Corporation) |
| Headquarters | Charlotte, North Carolina, USA |
| Stock Listing | NYSE: ALB |
| Primary Minerals | Lithium, Bromine |
| Flagship Assets | Salar de Atacama (Chile), Greenbush JV (Australia), Kings Mountain (USA) |
| FY2025 Revenue | $5.1 billion |
| FY2025 Adj. EBITDA | $1.1 billion |
| Liquidity (Dec 2025) | ~$3.2 billion (incl. $1.6bn cash) |
| Key Customers | Ford, Tesla (disclosed) |
| Website | investors.albemarle.com |
For context on the global lithium supply chain and producing country data, the USGS Lithium Statistics and Information page provides annual production and reserve figures by country.
This article is for informational purposes only and does not constitute investment advice. Prices and financial data are subject to change without notice.
What does Albemarle produce?
Albemarle produces battery-grade lithium carbonate and lithium hydroxide — the primary chemical forms of lithium used in EV and energy storage batteries. The company also produces bromine through a separate division. Lithium accounts for the majority of revenue.
Where are Albemarle’s main lithium operations located?
Albemarle’s core lithium operations are in the Salar de Atacama, Chile (brine), and at the Greenbush hard rock mine in Western Australia (JV with Tianqi Lithium and IGO Limited). A development-stage domestic US deposit at Kings Mountain, North Carolina, is in testing and not yet in commercial production.
How large is Albemarle’s lithium production capacity?
Albemarle is the world’s largest producer of converted lithium chemicals by volume. The company reported FY2025 revenue of $5.1 billion. Specific nameplate capacity figures by asset are not publicly disclosed in granular form; production volumes are reported in terms of lithium carbonate equivalent (LCE) tonnes.
What is Albemarle’s outlook for 2026?
Albemarle entered 2026 with approximately $3.2 billion in liquidity and is targeting an additional $100–150 million in cost savings. The company is idling its Kemerton hydroxide plant in Australia to reduce uncompetitive conversion costs. A partial lithium price recovery in 2026 has improved analyst sentiment, with upgrades from Goldman Sachs and J.P. Morgan cited in early 2026.
Who are Albemarle’s main competitors in lithium?
Primary competitors include SQM (Chile), Rio Tinto (following its March 2025 acquisition of Arcadium Lithium), Tianqi Lithium (China — also a JV partner at Greenbush), and Ganfeng Lithium (China). In the emerging US domestic market, Piedmont Lithium and Ioneer are smaller-scale competitors targeting IRA-qualifying supply.
